These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27387883)

  • 21. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
    Christopeit M; Bartholdy B
    Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics in acute myeloid leukemia.
    Plass C; Oakes C; Blum W; Marcucci G
    Semin Oncol; 2008 Aug; 35(4):378-87. PubMed ID: 18692688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics of paediatric acute myeloid leukaemia.
    Jones L; McCarthy P; Bond J
    Br J Haematol; 2020 Jan; 188(1):63-76. PubMed ID: 31804725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate.
    Das AB; Smith-Díaz CC; Vissers MCM
    Haematologica; 2021 Jan; 106(1):14-25. PubMed ID: 33099992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction.
    Niemöller C; Wehrle J; Riba J; Claus R; Renz N; Rhein J; Bleul S; Stosch JM; Duyster J; Plass C; Lutsik P; Lipka DB; Lübbert M; Becker H
    Commun Biol; 2021 Feb; 4(1):153. PubMed ID: 33526904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic landscape of acute myelogenous leukemia--moving toward personalized medicine.
    Lamba G; Zaidi SK; Luebbers K; Verschraegen C; Stein GS; Rosmarin A
    J Cell Biochem; 2014 Oct; 115(10):1669-72. PubMed ID: 24905899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
    Eriksson A; Lennartsson A; Lehmann S
    Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Newcombe AA; Gibson BES; Keeshan K
    Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
    Li S; Mason CE; Melnick A
    Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic therapies in acute myeloid leukemia: where to from here?
    Fennell KA; Bell CC; Dawson MA
    Blood; 2019 Nov; 134(22):1891-1901. PubMed ID: 31697822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolving molecular genetic landscape in acute myeloid leukaemia.
    Sanders MA; Valk PJ
    Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research progress of epigenetic drug decitabine in AML].
    Zhang R; Li HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1467-71. PubMed ID: 25338609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
    Ghoshal Gupta S; Baumann H; Wetzler M
    Leuk Res; 2008 Jul; 32(7):1005-14. PubMed ID: 18192010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
    Kim TK; Gore SD; Zeidan AM
    Semin Hematol; 2015 Jul; 52(3):172-83. PubMed ID: 26111464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
    Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
    Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Epigenetic" modification as therapy for acute myeloid leukemia.
    Schiffer CA
    Cancer; 2018 Jan; 124(2):242-244. PubMed ID: 29211296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.